Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 20

1.

Vitamin E decreases bone mass by stimulating osteoclast fusion.

Fujita K, Iwasaki M, Ochi H, Fukuda T, Ma C, Miyamoto T, Takitani K, Negishi-Koga T, Sunamura S, Kodama T, Takayanagi H, Tamai H, Kato S, Arai H, Shinomiya K, Itoh H, Okawa A, Takeda S.

Nat Med. 2012 Mar 4;18(4):589-94. doi: 10.1038/nm.2659. Erratum in: Nat Med. 2012 Sep;18(9):1445.

PMID:
22388090
2.

Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis.

Maeda K, Kobayashi Y, Udagawa N, Uehara S, Ishihara A, Mizoguchi T, Kikuchi Y, Takada I, Kato S, Kani S, Nishita M, Marumo K, Martin TJ, Minami Y, Takahashi N.

Nat Med. 2012 Feb 19;18(3):405-12. doi: 10.1038/nm.2653.

PMID:
22344299
3.

Osteoclast differentiation and activation.

Boyle WJ, Simonet WS, Lacey DL.

Nature. 2003 May 15;423(6937):337-42. Review.

PMID:
12748652
4.

VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors.

Lu X, Mu E, Wei Y, Riethdorf S, Yang Q, Yuan M, Yan J, Hua Y, Tiede BJ, Lu X, Haffty BG, Pantel K, Massagué J, Kang Y.

Cancer Cell. 2011 Dec 13;20(6):701-14. doi: 10.1016/j.ccr.2011.11.002. Epub 2011 Dec 1.

5.

Regulators of osteoclast differentiation and cell-cell fusion.

Miyamoto T.

Keio J Med. 2011;60(4):101-5. Review.

6.

Regulatory mechanisms of osteoblast and osteoclast differentiation.

Katagiri T, Takahashi N.

Oral Dis. 2002 May;8(3):147-59. Review.

PMID:
12108759
7.

New regulation mechanisms of osteoclast differentiation.

Nakashima T, Takayanagi H.

Ann N Y Acad Sci. 2011 Dec;1240:E13-8. doi: 10.1111/j.1749-6632.2011.06373.x. Review.

PMID:
22360322
8.

The osteoclast and its unique cytoskeleton.

Teitelbaum SL.

Ann N Y Acad Sci. 2011 Dec;1240:14-7. doi: 10.1111/j.1749-6632.2011.06283.x. Review.

PMID:
22172034
9.

Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer.

Schramek D, Leibbrandt A, Sigl V, Kenner L, Pospisilik JA, Lee HJ, Hanada R, Joshi PA, Aliprantis A, Glimcher L, Pasparakis M, Khokha R, Ormandy CJ, Widschwendter M, Schett G, Penninger JM.

Nature. 2010 Nov 4;468(7320):98-102. doi: 10.1038/nature09387. Epub 2010 Sep 29.

10.

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.

Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ.

Cell. 1998 Apr 17;93(2):165-76.

11.

Epigenetic regulation of osteoclast differentiation.

Yasui T, Hirose J, Aburatani H, Tanaka S.

Ann N Y Acad Sci. 2011 Dec;1240:7-13. doi: 10.1111/j.1749-6632.2011.06245.x. Review.

PMID:
22172033
12.

Differentiation of activated monocytes into osteoclast-like cells on a hydroxyapatite substrate: an in vitro study.

Narducci P, Nicolin V.

Ann Anat. 2009 Oct;191(4):349-55. doi: 10.1016/j.aanat.2009.02.009. Epub 2009 Apr 24.

PMID:
19447592
13.

Matrix-embedded cells control osteoclast formation.

Xiong J, Onal M, Jilka RL, Weinstein RS, Manolagas SC, O'Brien CA.

Nat Med. 2011 Sep 11;17(10):1235-41. doi: 10.1038/nm.2448.

14.

Osteoclast-osteoblast communication.

Matsuo K, Irie N.

Arch Biochem Biophys. 2008 May 15;473(2):201-9. doi: 10.1016/j.abb.2008.03.027. Epub 2008 Mar 29. Review.

PMID:
18406338
15.

Expression of XBP1s in bone marrow stromal cells is critical for myeloma cell growth and osteoclast formation.

Xu G, Liu K, Anderson J, Patrene K, Lentzsch S, Roodman GD, Ouyang H.

Blood. 2012 May 3;119(18):4205-14. doi: 10.1182/blood-2011-05-353300. Epub 2012 Mar 16.

16.

The adaptor protein p62/SQSTM1 in osteoclast signaling pathways.

McManus S, Roux S.

J Mol Signal. 2012 Jan 4;7:1. doi: 10.1186/1750-2187-7-1.

17.

Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway.

Wijenayaka AR, Kogawa M, Lim HP, Bonewald LF, Findlay DM, Atkins GJ.

PLoS One. 2011;6(10):e25900. doi: 10.1371/journal.pone.0025900. Epub 2011 Oct 4.

18.

Spleen serves as a reservoir of osteoclast precursors through vitamin D-induced IL-34 expression in osteopetrotic op/op mice.

Nakamichi Y, Mizoguchi T, Arai A, Kobayashi Y, Sato M, Penninger JM, Yasuda H, Kato S, DeLuca HF, Suda T, Udagawa N, Takahashi N.

Proc Natl Acad Sci U S A. 2012 Jun 19;109(25):10006-11. doi: 10.1073/pnas.1207361109. Epub 2012 Jun 5.

19.

Osteoblast and osteoclast crosstalks: from OAF to Ephrin.

Tamma R, Zallone A.

Inflamm Allergy Drug Targets. 2012 Jun;11(3):196-200. Review.

PMID:
22280242
20.

Denosumab in patients with cancer-a surgical strike against the osteoclast.

Brown JE, Coleman RE.

Nat Rev Clin Oncol. 2012 Jan 10;9(2):110-8. doi: 10.1038/nrclinonc.2011.197. Review.

PMID:
22231759

Supplemental Content

Support Center